3. - Universitätsklinik für FRAUENHEILKUNDE Innsbruck

7.
110
38. Mattle, V.; Hadziomerovic, D.; Zervomanolakis, I.; Murach, KF.; Hofer, S.;
Wildt, L.:
Pharmaceutical protection of the ovarian function with GnRH agonists: The
Innsbruck experience.
GEBURTSHILFE UND FRAUENHEILKUNDE. 2007; 67(5); 502-503.
39. Mattle, V.; Kraus-Kinsky, E.; Schulze, E.; Wildt, L.:
ACTH - test and molecular genetic analysis for the diagnosis of heterozygous
C21-hydroxylase deficiency.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. 2007;
115(5); S56-S56.
40. Neurauter, G.; Grahmann, AV.; Klieber, M.; Zeimet, A.; Ledochowski, M.;
Sperner-Unterweger, B.; Fuchs, D.:
Serum phenylalanine, tyrosine, neopterin and isoprostane in patients with
ovarian carcinoma.
EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007; 17(2); S305-S305.
41. Ott, HW.; Wildt, L.:
Oocyte cumulus complex pick-up rate depends on temperature and ovarian
follicular fluid.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. 2007;
115(2); S55-S55.
42. Ramoni, A.; Scheier, M.; Alge, A.; Brezinka, C.:
Fetal anemisation in infantile fibrosarcoma.
GEBURTSHILFE UND FRAUENHEILKUNDE. 2007; 67(5); 537-537.
43. Reimer, D.; Steppan, I.; Wiedemair, A.; Auer, D.; Marth, C.; Zeimet, AG.:
The clinical importance of the soluble splice variants of the Coxsackie adenovirus
receptor (CAR) in ovarian cancer.
GEBURTSHILFE UND FRAUENHEILKUNDE. 2007; 67(5); 505-505.
44. Reimer, D.; Steppan, I.; Wiedemair, A.; Fleischer, M.; Marth, C.; Zeimet, AG.:
The role of E2F3 isoforms in EGF-mediated proliferation in ovarian cancer.
GEBURTSHILFE UND FRAUENHEILKUNDE. 2007; 67(5); 529-529.